Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Zaja

Showing results (71-80 of 145) with videos related to

Pageof 15
Sort By:
Blood|December 3, 2003
Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical studyAndrea Gallamini, Caterina Stelitano, Roberta Calvi, et al.
Frontiers in Oncology|March 27, 2023
Comparison of first-line treatment with bendamustine plus rituximab versus R-CHOP for patients with follicular lymphoma grade 3A: Results of a retrospective study from the Fondazione Italiana LinfomiGloria Margiotta-Casaluci, Sara Bigliardi, Federica Cocito, et al.
Frontiers in Oncology|December 23, 2021
Venetoclax Shows Low Therapeutic Activity in BCL2-Positive Relapsed/Refractory Peripheral T-Cell Lymphoma: A Phase 2 Study of the Fondazione Italiana LinfomiLaura Ballotta, Pier Luigi Zinzani, Stefano Pileri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 18, 2012
Chlamydophila psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trialAndrés J M Ferreri, Silvia Govi, Elisa Pasini, et al.
Frontiers in Cardiovascular Medicine|November 24, 2022
Evolving trends in epidemiology and natural history of cardiac amyloidosis: 30-year experience from a tertiary referral center for cardiomyopathiesAldostefano Porcari, Valentina Allegro, Riccardo Saro, et al.
American Journal of Hematology|July 18, 2013
Bendamustine in chronic lymphocytic leukemia: outcome according to different clinical and biological prognostic factors in the everyday clinical practiceFrancesco Zaja, Michael Mian, Stefano Volpetti, et al.
Journal of Hematology & Oncology|January 8, 2026
Multicenter real-life evaluation of the Post-CAR prognostic index for patients with large B-cell lymphoma after CAR-T failureMirko Farina, Elena Maiolo, Chiara Ghiggi, et al.
American Journal of Hematology|June 4, 2026
Exploring the Burden on Patients Living With and Receiving Treatment for Immune Thrombocytopenia (ITP): Patient and Physician Perceptions From the ITP World Impact Survey (I-WISh) 2.0Nichola Cooper, James Bussel, Waleed Ghanima, et al.
British Journal of Haematology|July 9, 2016
Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopeniaElena Boggio, Casimiro L Gigliotti, Davide Rossi, et al.
American Journal of Hematology|February 25, 2016
Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA studyFrancesco Zaja, Wilma Barcellini, Silvia Cantoni, et al.
Pageof 15

Showing results (71-80 of 145) with videos related to

Sort By:
Pageof 15
Blood|December 3, 2003
Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical studyAndrea Gallamini, Caterina Stelitano, Roberta Calvi, et al.
Frontiers in Oncology|March 27, 2023
Comparison of first-line treatment with bendamustine plus rituximab versus R-CHOP for patients with follicular lymphoma grade 3A: Results of a retrospective study from the Fondazione Italiana LinfomiGloria Margiotta-Casaluci, Sara Bigliardi, Federica Cocito, et al.
Frontiers in Oncology|December 23, 2021
Venetoclax Shows Low Therapeutic Activity in BCL2-Positive Relapsed/Refractory Peripheral T-Cell Lymphoma: A Phase 2 Study of the Fondazione Italiana LinfomiLaura Ballotta, Pier Luigi Zinzani, Stefano Pileri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 18, 2012
Chlamydophila psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trialAndrés J M Ferreri, Silvia Govi, Elisa Pasini, et al.
Frontiers in Cardiovascular Medicine|November 24, 2022
Evolving trends in epidemiology and natural history of cardiac amyloidosis: 30-year experience from a tertiary referral center for cardiomyopathiesAldostefano Porcari, Valentina Allegro, Riccardo Saro, et al.
American Journal of Hematology|July 18, 2013
Bendamustine in chronic lymphocytic leukemia: outcome according to different clinical and biological prognostic factors in the everyday clinical practiceFrancesco Zaja, Michael Mian, Stefano Volpetti, et al.
Journal of Hematology & Oncology|January 8, 2026
Multicenter real-life evaluation of the Post-CAR prognostic index for patients with large B-cell lymphoma after CAR-T failureMirko Farina, Elena Maiolo, Chiara Ghiggi, et al.
American Journal of Hematology|June 4, 2026
Exploring the Burden on Patients Living With and Receiving Treatment for Immune Thrombocytopenia (ITP): Patient and Physician Perceptions From the ITP World Impact Survey (I-WISh) 2.0Nichola Cooper, James Bussel, Waleed Ghanima, et al.
British Journal of Haematology|July 9, 2016
Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopeniaElena Boggio, Casimiro L Gigliotti, Davide Rossi, et al.
American Journal of Hematology|February 25, 2016
Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA studyFrancesco Zaja, Wilma Barcellini, Silvia Cantoni, et al.
Pageof 15